526 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Acquired by Howard Capital Management Inc.

Howard Capital Management Inc. acquired a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 526 shares of the biotechnology company’s stock, valued at approximately $313,000.

A number of other hedge funds have also recently bought and sold shares of the company. Geode Capital Management LLC boosted its position in Axon Enterprise by 2.0% in the 3rd quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock valued at $710,103,000 after buying an additional 35,320 shares during the last quarter. Westfield Capital Management Co. LP boosted its position in Axon Enterprise by 12.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after buying an additional 127,769 shares during the last quarter. Champlain Investment Partners LLC boosted its position in Axon Enterprise by 13.9% in the 3rd quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock valued at $272,695,000 after buying an additional 83,265 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in Axon Enterprise by 1.6% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock valued at $224,281,000 after buying an additional 9,090 shares during the last quarter. Finally, Groupama Asset Managment bought a new position in Axon Enterprise in the 3rd quarter valued at $200,000. 79.08% of the stock is currently owned by institutional investors.

Insider Activity at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Michael Garnreiter sold 1,000 shares of the stock in a transaction on Monday, December 16th. The shares were sold at an average price of $639.69, for a total value of $639,690.00. Following the completion of the sale, the director now owns 24,259 shares in the company, valued at approximately $15,518,239.71. This trade represents a 3.96 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 8,711 shares of company stock valued at $5,631,561. 6.10% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

AXON has been the topic of a number of recent research reports. Craig Hallum lowered Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price objective on the stock. in a research report on Thursday, February 20th. Robert W. Baird increased their price objective on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. The Goldman Sachs Group raised their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. Northland Securities raised their price target on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. Finally, Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Three equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $561.31.

Axon Enterprise Stock Performance

AXON opened at $499.73 on Tuesday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The business’s 50-day moving average price is $616.95 and its two-hundred day moving average price is $520.78. The company has a market capitalization of $38.11 billion, a price-to-earnings ratio of 129.13, a P/E/G ratio of 5.43 and a beta of 1.05. Axon Enterprise, Inc. has a 1 year low of $265.32 and a 1 year high of $715.99.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.